End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.26 THB | -0.88% |
|
+0.89% | +26.26% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 28.25 times its estimated earnings per share for the ongoing year.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+26.26% | 845M | - | ||
-33.75% | 13.43B | B+ | ||
+5.14% | 11.95B | B+ | ||
-4.50% | 11.66B | B | ||
+13.11% | 11.08B | B+ | ||
+28.13% | 8.61B | B | ||
+20.47% | 7.63B | B- | ||
+8.23% | 6.45B | D | ||
+16.94% | 4.39B | B+ | ||
-8.15% | 4.11B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- VIBHA Stock
- Ratings Vibhavadi Medical Center